Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-03 Sale | 2022-03-04 5:54 pm | Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer | 2,044 | $11.38 | $23,261 | 37,811 (Direct) | View |
| 2021-08-30 Sale | 2021-09-01 6:08 pm | Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer | 1,982 | $14.2 | $28,144 | 3,352 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-01 Exercise | 2024-07-01 4:54 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles EVP and CFO | 16,667 | $0 | 110,971 (Direct) | View |
| 2024-07-01 Tax Withholding | 2024-07-01 4:54 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles EVP and CFO | 8,209 | $0.69 | 110,971 (Direct) | View |
| 2024-06-20 Tax Withholding | 2024-06-21 4:30 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles EVP and CFO | 16,417 | $0.73 | 119,180 (Direct) | View |
| 2024-06-20 Exercise | 2024-06-21 4:30 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles EVP and CFO | 33,333 | $0 | 119,180 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-09 4:30 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles EVP and CFO | 534,000 | $0 | 534,000 (Direct) | View |
| 2024-01-31 Tax Withholding | 2024-02-02 4:30 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles EVP and CFO | 24,552 | $1.24 | 158,798 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 4:30 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles EVP and CFO | 44,933 | $0 | 158,798 (Direct) | View |
| 2024-01-10 Exercise | 2024-01-12 5:27 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles EVP and CFO | 51,500 | $0 | 48,550 (Direct) | View |
| 2024-01-10 Tax Withholding | 2024-01-12 5:27 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles EVP and CFO | 28,325 | $0.97 | 48,550 (Direct) | View |
| 2024-01-10 Option Award | 2024-01-12 5:27 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles EVP and CFO | 51,500 | $0 | 48,550 (Direct) | View |
| 2023-07-19 Option Award | 2023-07-21 5:01 pm | N/A 2033-07-19 | AMARIN CORP PLC | AMRN | Reilly Thomas Charles SVP and CFO | 404,400 | $1.08 | 404,400 (Direct) | View |
| 2023-07-01 Tax Withholding | 2023-07-05 4:46 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles SVP and CFO | 8,209 | $1.19 | 58,708 (Direct) | View |
| 2023-07-01 Exercise | 2023-07-05 4:46 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles SVP and CFO | 16,667 | $0 | 58,708 (Direct) | View |
| 2023-06-20 Tax Withholding | 2023-06-22 5:10 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles SVP and CFO | 16,417 | $1.19 | 83,583 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-22 5:10 pm | N/A N/A | AMARIN CORP PLC | AMRN | Reilly Thomas Charles SVP and CFO | 33,334 | $0 | 83,583 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 9:43 pm | N/A 2033-02-21 | AMARIN CORP PLC | AMRN | Reilly Thomas Charles SVP and CFO | 454,400 | $0 | 454,400 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 8:11 pm | N/A 2032-07-01 | AMARIN CORP PLC | AMRN | Reilly Thomas Charles SVP and CFO | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-01 4:18 pm | N/A N/A | Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer | 5,333 | $10.29 | 79,855 (Direct) | View |
| 2022-02-25 Option Award | 2022-03-01 4:18 pm | N/A 2032-02-25 | Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer | 60,000 | $0 | 79,855 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 5:26 pm | N/A N/A | Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer | 11,170 | $0 | 14,522 (Direct) | View |
| 2021-08-24 Option Award | 2021-08-26 6:18 pm | N/A N/A | Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer | 5,334 | $0 | 5,334 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-07 4:50 pm | N/A 2030-10-01 | Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer | 175,000 | $0 | 175,000 (Direct) | View |